AdaptHealth (AHCO) Capital Expenditures (2019 - 2026)
AdaptHealth's (AHCO) quarterly Capital Expenditures came in at $102.5 million in Q1 2026, up 7.24% year-on-year from $95.6 million in Q1 2025, and down 1.34% quarter-over-quarter from $103.9 million in Q4 2025.
AdaptHealth (AHCO) Capital Expenditures (2019 - 2026) Analysis & Trends
AdaptHealth's Capital Expenditures history runs 8 years deep, the most recent figure standing at $102.5 million for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 7.24% year-over-year to $102.5 million in Q1 2026; TTM through Mar 2026 was $389.3 million, a 255.1% increase from a year earlier, with the FY2025 full-year figure at $382.4 million, up 581.34% from the prior year.
- Capital Expenditures fell to $102.5 million in Q1 2026 per AHCO's latest filing, from $103.9 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $136.8 million in Q2 2023 and bottomed at -$212.9 million in Q4 2023.
- The 5-year median for Capital Expenditures is $77.2 million (2022), against an average of $35.4 million.
- Across the five-year window, Capital Expenditures sank 699.27% in 2023 and soared 1004.92% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at -$26.6 million in 2022, then sank by 699.27% to -$212.9 million in 2023, then surged by 104.42% to $9.4 million in 2024, then surged by 1004.92% to $103.9 million in 2025, then decreased by 1.34% to $102.5 million in 2026.
- Per Business Quant, the three latest AHCO Capital Expenditures figures stand at $102.5 million (Q1 2026), $103.9 million (Q4 2025), and $94.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 76.60 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 178.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -85.46 Mn |
| 10 | AdaptHealth | 1.47 Bn | 1.42 Bn | 111.50 Mn | 102.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.50 Mn |
| Mar 31, 2026 | 102.50 Mn |
| Dec 31, 2025 | 103.90 Mn |
| Dec 31, 2025 | 103.90 Mn |
| Sep 30, 2025 | 94.24 Mn |
| Sep 30, 2025 | 94.24 Mn |
| Jun 30, 2025 | 88.67 Mn |
| Jun 30, 2025 | 88.67 Mn |
| Mar 31, 2025 | 95.59 Mn |
| Mar 31, 2025 | 95.59 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | -122.44 Mn |
| Sep 30, 2024 | -122.44 Mn |
| Jun 30, 2024 | 127.09 Mn |
| Jun 30, 2024 | 127.09 Mn |
| Mar 31, 2024 | 42.07 Mn |
| Mar 31, 2024 | 42.07 Mn |
| Dec 31, 2023 | -212.95 Mn |
| Dec 31, 2023 | -212.95 Mn |